Indonesia Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2026
Indonesia Pharmaceuticals Market @Summary, Competitive Analysis and Forecast to 2026
SUMMARY
Pharmaceuticals in Indonesia industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2016-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Pharmaceuticals in Indonesia industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2016-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Indonesian pharmaceuticals market had total revenues of $5.0 billion in 2021, representing a compound annual growth rate (CAGR) of -0.2% between 2016 and 2021.
- Growing FDI into the Indonesian pharmaceuticals market is projected to have a positive impact on market growth.
- The increasing threat of competition from India and China, as manufacturing and export capacity increased in these countries, could act as a barrier to growth in the Indonesian market.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Indonesia
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Indonesia
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Indonesia pharmaceuticals market with five year forecasts by both value and volume
- What was the size of the Indonesia pharmaceuticals market by value in 2021?
- What will be the size of the Indonesia pharmaceuticals market in 2026?
- What factors are affecting the strength of competition in the Indonesia pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up Indonesia's pharmaceuticals market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. Are there any other notable players in the market?
7.4. What are the strengths of leading players?
7.5. What strategies do leading players follow?
8 COMPANY PROFILES
8.1. Sanofi SA
8.2. PT Kimia Farma Tbk
8.3. Novartis AG
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. Are there any other notable players in the market?
7.4. What are the strengths of leading players?
7.5. What strategies do leading players follow?
8 COMPANY PROFILES
8.1. Sanofi SA
8.2. PT Kimia Farma Tbk
8.3. Novartis AG
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Indonesia pharmaceuticals market value: $ billion, 2016–21
Table 2: Indonesia pharmaceuticals market geography segmentation: $ billion, 2021
Table 3: Indonesia pharmaceuticals market value forecast: $ billion, 2021–26
Table 4: Indonesia pharmaceuticals market share: % share, by value, 2021
Table 5: Sanofi SA: key facts
Table 6: Sanofi SA: Annual Financial Ratios
Table 7: Sanofi SA: Key Employees
Table 8: Sanofi SA: Key Employees Continued
Table 9: PT Kimia Farma Tbk: key facts
Table 10: PT Kimia Farma Tbk: Annual Financial Ratios
Table 11: PT Kimia Farma Tbk: Key Employees
Table 12: Novartis AG: key facts
Table 13: Novartis AG: Annual Financial Ratios
Table 14: Novartis AG: Key Employees
Table 15: Novartis AG: Key Employees Continued
Table 16: Indonesia size of population (million), 2017–21
Table 17: Indonesia gdp (constant 2005 prices, $ billion), 2017–21
Table 18: Indonesia gdp (current prices, $ billion), 2017–21
Table 19: Indonesia inflation, 2017–21
Table 20: Indonesia consumer price index (absolute), 2017–21
Table 21: Indonesia exchange rate, 2017–21
Table 1: Indonesia pharmaceuticals market value: $ billion, 2016–21
Table 2: Indonesia pharmaceuticals market geography segmentation: $ billion, 2021
Table 3: Indonesia pharmaceuticals market value forecast: $ billion, 2021–26
Table 4: Indonesia pharmaceuticals market share: % share, by value, 2021
Table 5: Sanofi SA: key facts
Table 6: Sanofi SA: Annual Financial Ratios
Table 7: Sanofi SA: Key Employees
Table 8: Sanofi SA: Key Employees Continued
Table 9: PT Kimia Farma Tbk: key facts
Table 10: PT Kimia Farma Tbk: Annual Financial Ratios
Table 11: PT Kimia Farma Tbk: Key Employees
Table 12: Novartis AG: key facts
Table 13: Novartis AG: Annual Financial Ratios
Table 14: Novartis AG: Key Employees
Table 15: Novartis AG: Key Employees Continued
Table 16: Indonesia size of population (million), 2017–21
Table 17: Indonesia gdp (constant 2005 prices, $ billion), 2017–21
Table 18: Indonesia gdp (current prices, $ billion), 2017–21
Table 19: Indonesia inflation, 2017–21
Table 20: Indonesia consumer price index (absolute), 2017–21
Table 21: Indonesia exchange rate, 2017–21
LIST OF FIGURES
Figure 1: Indonesia pharmaceuticals market value: $ billion, 2016–21
Figure 2: Indonesia pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 3: Indonesia pharmaceuticals market value forecast: $ billion, 2021–26
Figure 4: Forces driving competition in the pharmaceuticals market in Indonesia, 2021
Figure 5: Drivers of buyer power in the pharmaceuticals market in Indonesia, 2021
Figure 6: Drivers of supplier power in the pharmaceuticals market in Indonesia, 2021
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Indonesia, 2021
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Indonesia, 2021
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Indonesia, 2021
Figure 10: Indonesia pharmaceuticals market share: % share, by value, 2021
Figure 1: Indonesia pharmaceuticals market value: $ billion, 2016–21
Figure 2: Indonesia pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 3: Indonesia pharmaceuticals market value forecast: $ billion, 2021–26
Figure 4: Forces driving competition in the pharmaceuticals market in Indonesia, 2021
Figure 5: Drivers of buyer power in the pharmaceuticals market in Indonesia, 2021
Figure 6: Drivers of supplier power in the pharmaceuticals market in Indonesia, 2021
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Indonesia, 2021
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Indonesia, 2021
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Indonesia, 2021
Figure 10: Indonesia pharmaceuticals market share: % share, by value, 2021
